NDC00056-0521-28 (Carbidopa And Levodopa Extended Release Tablets) by Bristol Myers Squibb Company - Request a Quote Now

Part No. : NDC00056-0521-28 Alternate P/N : NDC00056052128 Manufacturer : Bristol Myers Squibb Company
CAGE Code : 04490 Item Name : Carbidopa And Levodopa Extended Release Tablets NSN : 6505-01-343-3483

You can send a request for quote for p/n NDC00056-0521-28 to ASAP Semiconductor using justpartsunlimited.com. This part is manufactured by Bristol Myers Squibb Company (CAGE Code 04490). The description of it is Carbidopa And Levodopa Extended Release Tablets. The national stock number associated with this part is NSN 6505013433483. This part belongs to FSC  part family. An associate from ASAP Semiconductor will respond within 15 minutes to your query. It is our pleasure to help you with NDC00056-0521-28 part requirements.

Required fields compulsory *

Contact Information

Note: We will not share your information to any third parties.

  * By clicking this box, I acknowledge that I have read and accept the ASAP Semiconductor Terms & Conditions and agree that all quotes and purchase orders are exclusively subject to the ASAP Semiconductor Terms and Conditions.

  • I consent to receive email communications from ASAP Semiconductor and can unsubscribe at any time.
  • ASAP Semiconductor is a wholly independent aftermarket parts distributor.
  • This website is intended for quotations based on part numbers only. Please DO NOT submit drawings, technical data, or other specifications through this portal.

NSN Information for Part Number NDC00056-0521-28 with NSN 6505-01-343-3483, 6505013433483

NSNFSCNIINCLSHazmatDEMILCancelled NSN
6505-01-343-3483

Item Description:

Carbidopa And Levodopa Extended Release Tablets

6505013433483QP
CIICHCCESDPMICCriticalityENAC
U A
Part NumberISCRNVCRNCCHCCMSDSSADC
Ndc00056-0521-28223

Characteristics Data of NSN 6505-01-343-3483, 6505013433483

MRCCriteriaCharacteristic
AKJAActive Medicament Medicinal Strength50.000 MILLIGRAMS CARBIDOPA ACTIVE INGREDIENT AND
CXCYPart Name Assigned By Controlling AgencyCARBIDOPA AND LEVODOPA EXTENDED-RELEASE TABLETS 100S BT
CBBLFeatures ProvidedUNIT DOSE
CRLKPrimary Container Content Quantity100.000 TABLETS
AKJAActive Medicament Medicinal Strength200.000 MILLIGRAMS LEVODOPA ACTIVE INGREDIENT
MRCDecoded RequirementClear Text Reply
CQCTPrimary Container TypeSTRIP
ASAP Semiconductor's Certifications and Memberships